GH Research (GHRS) Interest & Investment Income (2022 - 2025)
GH Research's (GHRS) quarterly Interest & Investment Income came in at $2.5 million in Q4 2025, up 18.88% year-on-year from $2.1 million in Q4 2024, and down 9.74% quarter-over-quarter from $2.8 million in Q3 2025.
GH Research (GHRS) Interest & Investment Income (2022 - 2025) Analysis & Trends
GH Research's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- On a quarterly basis, Interest & Investment Income rose 18.88% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $11.1 million, a 12.71% increase from a year earlier, with the FY2025 full-year figure at $11.1 million, up 12.71% from the prior year.
- Interest & Investment Income retreated to $2.5 million in Q4 2025 per GHRS's latest filing, from $2.8 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.1 million in Q2 2025 and bottomed at $1.2 million in Q4 2022.
- The 4-year median for Interest & Investment Income is $2.5 million (2024), against an average of $2.4 million.
- Across the five-year window, Interest & Investment Income jumped 151.2% in 2023 and declined 27.86% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $1.2 million in 2022, then soared by 151.2% to $2.9 million in 2023, then slipped by 27.86% to $2.1 million in 2024, then increased by 18.88% to $2.5 million in 2025.
- Per Business Quant, the three latest GHRS Interest & Investment Income figures stand at $2.5 million (Q4 2025), $2.8 million (Q3 2025), and $3.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | GH Research | 1.70 Bn | 1.45 Bn | - | 2.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.78 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 1.17 Mn |